Sphera Funds Management Ltd. Edgewise Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$8.08 - $13.58 $484,800 - $814,800
60,000 New
60,000 $590,000
Q2 2021

Aug 17, 2021
SELL
$21.33 - $30.25 $2.13 Million - $3.03 Million
-100,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$30.0 - $35.99 $3 Million - $3.6 Million
100,000 New
100,000 $3.25 Million

Others Institutions Holding EWTX

# of Institutions
192
Shares Held
100M
Call Options Held
2.17M
Put Options Held
410K
View Full List

About Edgewise Therapeutics, Inc.

EWTX Quotes by TradingView
  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.86B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email